Cullinan Therapeutics, Inc. (CGEM) Operating Lease, Right-of-Use Asset USD 2021 - 2024

Historical data

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Cullinan Therapeutics, Inc. quarterly Operating Lease, Right-of-Use Asset history and growth rate from 2021 to 2024.
  • Cullinan Therapeutics, Inc. Operating Lease, Right-of-Use Asset for the quarter ending March 31, 2024 was $2.34 M, a 38.8% decline year-over-year.
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q1 2024 $2.34 M -$1.48 M -38.8% Mar 31, 2024 10-Q 2024-05-15
Q4 2023 $2.54 M -$1.59 M -38.4% Dec 31, 2023 10-Q 2024-05-15
Q3 2023 $2.93 M -$1.57 M -34.9% Sep 30, 2023 10-Q 2023-11-08
Q2 2023 $3.5 M +$2.43 M +226% Jun 30, 2023 10-Q 2023-08-10
Q1 2023 $3.82 M +$2.63 M +220% Mar 31, 2023 10-Q 2023-05-11
Q4 2022 $4.13 M +$4.13 M Dec 31, 2022 10-K 2024-03-14
Q3 2022 $4.5 M Sep 30, 2022 10-Q 2022-11-14
Q2 2022 $1.07 M Jun 30, 2022 10-Q 2022-08-10
Q1 2022 $1.19 M Mar 31, 2022 10-Q 2022-05-16
Q4 2021 $0 Dec 31, 2021 10-K 2023-03-09
* An asterisk sign (*) next to the value indicates that the value is likely invalid.